CTVA vs NTR

For growth investors, Nutrien Ltd.

(NTR) is the stronger pick with 5. 3% revenue growth year-over-year, versus 2. 9% for Corteva, Inc. (CTVA). Nutrien Ltd. (NTR) offers the better valuation at 15. 6x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Corteva, Inc. (CTVA) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Nutrien Ltd.

(NTR) is the cheapest at 15. 6x versus Corteva, Inc. at 51. 1x. On forward P/E, Nutrien Ltd. is actually cheaper at 13. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Nutrien Ltd. wins at 0. 32x versus Corteva, Inc. 's 1. 87x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Corteva, Inc.

(CTVA) delivered a total return of +75. 4%, compared to +41. 2% for Nutrien Ltd. (NTR). Over 10 years, the gap is even starker: CTVA returned +195. 9% versus NTR's +64. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Nutrien Ltd.

(NTR) is the lower-risk stock at -0. 07β versus Corteva, Inc. 's 0. 29β — meaning CTVA is approximately -505% more volatile than NTR relative to the S&P 500. On balance sheet safety, Corteva, Inc. (CTVA) carries a lower debt/equity ratio of 11% versus 51% for Nutrien Ltd. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Nutrien Ltd.

(NTR) is pulling ahead at 5. 3% versus 2. 9% for Corteva, Inc. (CTVA). On earnings-per-share growth, the picture is similar: Nutrien Ltd. grew EPS 248. 5% year-over-year, compared to 23. 1% for Corteva, Inc.. Over a 3-year CAGR, CTVA leads at -0. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Nutrien Ltd.

(NTR) is the more profitable company, earning 8. 4% net margin versus 6. 3% for Corteva, Inc. — meaning it keeps 8. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTVA leads at 15. 1% versus 14. 5% for NTR. At the gross margin level — before operating expenses — CTVA leads at 43. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Nutrien Ltd. (NTR) is the more undervalued stock at a PEG of 0. 32x versus Corteva, Inc. 's 1. 87x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Nutrien Ltd. (NTR) trades at 13. 0x forward P/E versus 22. 3x for Corteva, Inc. — 9. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NTR: 14. 1% to $84. 25.

All stocks in this comparison pay dividends.

Nutrien Ltd. (NTR) offers the highest yield at 3. 0%, versus 0. 9% for Corteva, Inc. (CTVA).

For long-horizon retirement investors, Nutrien Ltd.

(NTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 07), 3. 0% yield). Both have compounded well over 10 years (NTR: +64. 0%, CTVA: +195. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CTVA is a mid-cap quality compounder stock; NTR is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.